Functional outcomes of inflammatory bowel disease associated variants
Functional outcomes of inflammatory bowel disease associated variants
批准号:
10321645
负责人:
CLARA ABRAHAM
金额:
$56.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-18 至 2023-07-31
关键词:
AutoimmuneAutoimmunityAutomobile DrivingCell physiologyCellsColony-forming unitsDendritic CellsDevelopmentDiseaseDisease susceptibilityEndoplasmic ReticulumEquilibriumFutureGenesGeneticGenetic DiseasesGenetic PolymorphismGenetic Predisposition to DiseaseGenetic VariationHumanHuman GeneticsImmune System DiseasesImmune responseIndividualInfectionInflammatoryInflammatory Bowel DiseasesJAK2 geneLinkage DisequilibriumMAP3K8 geneMediatingMicrobeMicrobial GeneticsMolecularOutcomePathogenesisPathway interactionsPatientsPattern recognition receptorPlayPredispositionProteinsQuantitative Trait LociReactive Nitrogen SpeciesReactive Oxygen SpeciesReceptor ActivationRegulationRing Finger DomainRoleSTAT3 geneSignal TransductionSingle Nucleotide PolymorphismSystemTNFSF15 geneTestingToll-like receptorsUlcerative ColitisVariantantimicrobialcohortcytokinedensityfunctional outcomesgain of functiongene functiongenomic locushuman diseaseimprovedin vivoinsightinter-individual variationknock-downmacrophagemicrobialmonocytemycobacterialnew therapeutic targetnovelnovel therapeuticsresponserisk varianttherapeutic candidatetherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The interplay between microbial and genetic susceptibility factors is central to the development of
inflammatory bowel disease (IBD). Innate mechanisms, in particular through pattern recognition receptor
(PRR) pathways, are the initiating drivers of host responses to microbes. Of the 200 loci associated to
IBD, a number of genes modulate host PRR responses at many levels, and confer some of the largest
genetic effect sizes observed in autoimmunity. Despite the significant recent discoveries in IBD-
associated genetic loci, the functional consequences of the majority of these loci have yet to be identified.
A central outcome of PRR activation by microbial products is induction of cytokines and microbial
clearance pathways. IBD is largely characterized by dysregulated cytokines and anti-microbial
responses, and modulation of cytokines plays a primary role in IBD treatment. Inter-individual variation in
PRR-induced outcomes influences the critical balance between susceptibility to infection and
inflammatory diseases. We hypothesize that polymorphisms in multiple IBD-associated genes contribute
to inter-individual variation in PRR-induced cytokine secretion and microbial clearance pathways.
Systematic, well-powered studies comprehensively defining the functional alterations driven by disease-
associated human variation can provide enormous insight into central mechanisms of IBD; leveraging
naturally occurring human genetic variation to systematically “perturb” an experimental system represents
an advantageous approach for precisely defining established and novel PRR-mediated mechanisms of
signaling, cytokine secretion and microbial clearance. Therefore, we will utilize a large, well-powered
cohort to screen for IBD-associated polymorphisms contributing to the variation in PRR-initiated cytokine
secretion across individuals, and then define the molecular mechanisms wherein the implicated IBD-
associated genes, as well as the identified polymorphisms, regulate PRR-induced signaling, cytokine
secretion, and microbial clearance pathways.
Relevance
These combined studies will provide insight into whether those IBD-associated loci that regulate PRR-
induced signaling, cytokine secretion and bacterial clearance do so through a loss- or gain-of-function, the
mechanisms wherein the implicated genes mediate their contributions to these PRR-induced outcomes,
and the specific consequences of the polymorphisms on gene function through examination of monocyte-
derived cells from selected carriers. These comprehensive and mechanistic studies will be crucial for
future studies that will examine gene consequences in vivo and ultimately, in the context of disease
targeting.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial Mechanisms Promoting Innate and Intestinal Immunity
-
批准号:10635818
-
项目类别:
-
资助金额:$51.59万
-
财政年份:2023
-
负责人:CLARA ABRAHAM
-
依托单位:
Mechanisms Regulating Innate Immune Responses
-
批准号:9194584
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2016
-
负责人:CLARA ABRAHAM
-
依托单位:
Mechanisms Regulating Innate Immune Responses
-
批准号:9304966
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2016
-
负责人:CLARA ABRAHAM
-
依托单位:
Mechanisms Regulating Innate Immune Responses
-
批准号:8915927
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2014
-
负责人:CLARA ABRAHAM
-
依托单位:
Functional outcomes of inflammatory bowel disease associated variants
-
批准号:8557263
-
项目类别:
-
资助金额:$36.21万
-
财政年份:2013
-
负责人:CLARA ABRAHAM
-
依托单位:
Functional outcomes of inflammatory bowel disease associated variants
-
批准号:8858628
-
项目类别:
-
资助金额:$36.21万
-
财政年份:2013
-
负责人:CLARA ABRAHAM
-
依托单位:
Functional outcomes of inflammatory bowel disease associated variants
-
批准号:8737251
-
项目类别:
-
资助金额:$36.21万
-
财政年份:2013
-
负责人:CLARA ABRAHAM
-
依托单位:
Functional outcomes of inflammatory bowel disease associated variants
-
批准号:10733023
-
项目类别:
-
资助金额:$72.67万
-
财政年份:2013
-
负责人:CLARA ABRAHAM
-
依托单位:
Functional outcomes of inflammatory bowel disease associated variants
-
批准号:9277453
-
项目类别:
-
资助金额:$36.21万
-
财政年份:2013
-
负责人:CLARA ABRAHAM
-
依托单位:
IL-23/Th17 pathways and Inflammatory Bowel Disease
-
批准号:8535918
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2012
-
负责人:CLARA ABRAHAM
-
依托单位:
Mechanisms of Chronic Nod2-mediated Effects in Human Macrophages
-
批准号:7850040
-
项目类别:
-
资助金额:$3.58万
-
财政年份:2009
-
负责人:CLARA ABRAHAM
-
依托单位:
Mechanisms of Chronic Nod2-mediated Effects in Human Macrophages
-
批准号:8282923
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2008
-
负责人:CLARA ABRAHAM
-
依托单位:
Mechanisms of Chronic Nod2-mediated Effects in Human Macrophages
-
批准号:7656767
-
项目类别:
-
资助金额:$33.1万
-
财政年份:2008
-
负责人:CLARA ABRAHAM
-
依托单位:
Mechanisms of Chronic Nod2-mediated Effects in Human Macrophages
-
批准号:8068770
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2008
-
负责人:CLARA ABRAHAM
-
依托单位:
THE ROLE OF LFA-1 IN T CELL ACTIVATION
-
批准号:6516792
-
项目类别:
-
资助金额:$8.95万
-
财政年份:2001
-
负责人:CLARA ABRAHAM
-
依托单位:
THE ROLE OF LFA-1 IN T CELL ACTIVATION
-
批准号:6902578
-
项目类别:
-
资助金额:$12.48万
-
财政年份:2001
-
负责人:CLARA ABRAHAM
-
依托单位:
THE ROLE OF LFA-1 IN T CELL ACTIVATION
-
批准号:6634767
-
项目类别:
-
资助金额:$12.48万
-
财政年份:2001
-
负责人:CLARA ABRAHAM
-
依托单位:
THE ROLE OF LFA-1 IN T CELL ACTIVATION
-
批准号:6190725
-
项目类别:
-
资助金额:$8.23万
-
财政年份:2001
-
负责人:CLARA ABRAHAM
-
依托单位:
THE ROLE OF LFA-1 IN T CELL ACTIVATION
-
批准号:6752767
-
项目类别:
-
资助金额:$12.48万
-
财政年份:2001
-
负责人:CLARA ABRAHAM
-
依托单位:
海外基金